| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.18 | 0.004 |